News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

France Suspends Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos and Competact Over Bladder Cancer Concerns


6/9/2011 10:19:41 AM

France's drug safety authority said on Thursday it had suspended the use of two diabetes treatments from Japan's Takeda Pharmaceutical Co. Ltd. (4502.T) because of concerns about cancer risks.

Read at Reuters
Read at SF Gate


comments powered by Disqus
Reuters
SF Gate
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES